Alto Neuroscience, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Savitz Adam | CHIEF MEDICAL OFFICER | Purchase | 1,388 | $13.15 | $18,252 | 36,920 | Jul 10, 2024 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Purchase | 4,550 | $16.56 | $75,348 | 26,866 | Mar 28, 2024 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Award / Grant | 19,153 | — | — | 20,716 | Mar 1, 2024 |
| Etkin Amit | PRESIDENT AND CEO | Award / Grant | 34,711 | — | — | 1,240,176 | Mar 1, 2024 |
| Chen Po Yu (Jeff) | — | C | 39,259 | — | — | 39,259 | Feb 6, 2024 |
| Etkin Amit | PRESIDENT AND CEO | C | 11,777 | — | — | 1,202,340 | Feb 6, 2024 |
| Savitz Adam | CHIEF MEDICAL OFFICER | C | 7,851 | — | — | 7,851 | Feb 6, 2024 |
| Cox Christopher Nixon | — | C | 588,898 | — | — | 588,898 | Feb 6, 2024 |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Purchase | 1,563 | $16.00 | $25,008 | 1,563 | Feb 6, 2024 |
| York Gwill | — | C | 23,917 | — | — | 23,917 | Feb 6, 2024 |
| Alpha Wave Global, LP | — | C | 1,962,995 | — | — | 1,962,995 | Feb 6, 2024 |
| Apeiron Investment Group Ltd. | — | C | 251,881 | — | — | 251,881 | Feb 6, 2024 |